Workflow
Rigel(RIGL) - 2025 Q1 - Earnings Call Transcript

Rigel Pharmaceuticals (RIGL) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Raymond Furey - Executive VP, General Counsel & Corporate SecretaryRaul Rodriguez - President and CEODavid Santos - Executive VP & Chief Commercial OfficerLisa Rojkjaer - Executive VP & Chief Medical OfficerDean Schorno - Executive VP & CFOJoe Pantginis - Managing Director Conference Call Participants Kalpit Patel - Senior Biotech Research AnalystFarzin Haque - Senior VP & Biotechnology Equity Research Analyst O ...